VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹33.90 | ₹21.31 | ₹19.87 | ₹30.47 | ₹50.04 |
What is the latest Earnings Per Share (EPS) of VENUS REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹33.90 |
| Mar2025 | ₹21.31 |
| Mar2024 | ₹19.87 |
| Mar2023 | ₹30.47 |
| Mar2022 | ₹50.04 |
How is Earnings Per Share (EPS) of VENUS REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹33.90 | 59.08 | |
| Mar2025 | ₹21.31 | 7.25 | |
| Mar2024 | ₹19.87 | -34.79 | |
| Mar2023 | ₹30.47 | -39.11 | |
| Mar2022 | ₹50.04 | - | |
Compare Earnings Per Share (EPS) of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,318.7 Cr | -2.8% | 3.2% | 273.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -2.8% |
3.2% |
273.6% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses